CIK 0001800315 · Non-accelerated filer<br>Smaller reporting company
Damora Therapeutics, Inc.
Sign in to watch- Ticker
- DMRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 371957007
- Phone
- (781) 281-9020
- Business address
- 100 FIFTH AVENUE, SUITE 700, WALTHAM, MA, 02451
- Former names
- Galecto, Inc., Galecto Inc.
- EFFECT Other Notice of Effectiveness
- S-8 POS Other Post-effective Amendment
- S-8 POS Other Post-effective Amendment
- POSASR Other POSASR
- S-8 POS Other Post-effective Amendment
- S-8 POS Other Post-effective Amendment
- S-8 POS Other Post-effective Amendment
- S-8 POS Other Post-effective Amendment
- S-8 POS Other Post-effective Amendment
- S-8 POS Other Post-effective Amendment
- POS AM Other Post-effective Amendment for Registration Statement
- 8-A12B/A Other Registration Statement
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-3ASR Offering Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
Page 1 of 4 · 77 filings